Oslo, Norway

Mona Moller


 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Mona Moller

Introduction

Mona Moller is an accomplished inventor based in Oslo, Norway. She has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrugs of vitamin K. With a total of 2 patents to her name, Moller is recognized for her innovative approaches to enhancing the bioavailability of vitamin K compounds.

Latest Patents

Mona Moller's latest patents include groundbreaking work on prodrugs of vitamin K2. The first patent focuses on prodrugs of MK-7, where the diketone is converted to a monosubstituted or disubstituted ester type derivative. These compounds have been shown to effectively deliver MK-7 in plasma. The second patent also pertains to prodrugs of vitamin K2, emphasizing similar modifications to enhance the efficacy of MK-7.

Career Highlights

Mona Moller is currently associated with Kappa Bioscience AS, a company dedicated to advancing vitamin K research and applications. Her work has positioned her as a key figure in the pharmaceutical industry, particularly in the area of vitamin K prodrugs.

Collaborations

Moller collaborates with notable colleagues such as Marcel Sandberg and Inger Reidun Aukrust, contributing to a dynamic research environment focused on innovative solutions in health and medicine.

Conclusion

Mona Moller exemplifies the spirit of innovation in the pharmaceutical field through her work on vitamin K prodrugs. Her contributions are paving the way for new treatments and improved health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…